Interested in on-demand education through didactic lectures, discussions and a compendium of case reviews from other leading experts? Find a list of webinars and webcasts from reputable societies, including American Society of Pain & Neuroscience (ASPN), Pacific Spine & Pain Society (PSPS), Women Innovators in Pain Management (WIPM) and Florida Society of Pain and Neuroscience (FSPN) below to learn more about identifying and treating patients with the mild® Procedure.
Free On-Demand Education
APP Imaging Workshop - A Collaborative Approach to mild® Patient Selection
In this webinar, moderators James Lynch, PA and Kelsey Kimball, PA, partnered with their physicians Dr. Michael Verdolin and Dr. Ajay Antony to provide an interactive workshop focused on enhancing imaging review skillsets. View the interactive workshop where they cover imaging basics, navigating software, measuring the ligament and more!
Women Innovators in Pain Management Webinar: Expanding Opportunities to Treat LSS Patients Earlier & More Often with PILD
In this Women Innovators in Pain Management (WIPM) webinar, moderator Jacqueline Weisbein, DO and faculty members Jessica Jameson, MD and FASA Lindsay N. Shroyer, MD discuss how to evaluate patients to determine appropriate candidates for PILD, use safety and efficacy data to understand where PILD fits in the LSS treatment algorithm, understand basic tenants and advantages of the Streamlined Technique and apply best practices for forging relationships with surgeon colleagues to help more patients.
“This procedure, you know, it’s not just for patients with stenosis… It’s performed with patients with stenosis, but they have other comorbidities… In my patients that are 70 years and older, they have facet arthropathy, they have stenosis, they have disc bulge and having those other conditions doesn’t make this a contraindication. You can still do this procedure on patients with those other comorbidities as long as they have greater than 2.5 millimeters of ligamentum flavum hypertrophy,” Dr. Shroyer says.
PSPS Expanding Opportunities to Treat LSS Patients Earlier & More Often with PILD
In this Pacific Spine & Pain Society (PSPS) training webinar, moderator Jason Pope, MD, and faculty members Steven Falowski, MD; Denis Patterson, DO and Jacqueline Weisbein, DO discuss how to evaluate patients to determine appropriate candidates for PILD, use safety and efficacy data to understand where PILD fits in the LSS treatment algorithm, understand basic tenants and advantages of the technique and apply best practices for forging relationships with surgeon colleagues to help more patients.
“We have highly under-treated lumbar spinal stenosis patients and the idea of just being able to either offer epidural steroid injections (ESIs) or jumping right to surgery is, I think, becoming a thing of the past and it’s not going to be part of our algorithm in that same manner,” Dr. Falowski says.
In this Florida Society of Pain and Neuroscience webinar, moderator Steven Falowski, MD and faculty members Nomen Azeem, MD; Michael Esposito, MD; Jackie Weisbein, DO; Stanley Golovac, MD; Navdeep Jassal, MD and Miguel Attias, MD discuss pathogenesis of LSS, spinal stenosis treatment algorithm, Vertos Medical’s mild® Procedure and more.
“We’re at a very pivotable point in terms of interventional pain. We’re crossing into the crossroads of interventional spine or minimally invasive spine, so let’s progress forward,” Dr. Jassal shares.
ASPN Virtual Think Tank Session 5: Minimally Invasive Spine Therapies
In this ASPN Virtual Think Tank, moderators Timothy Deer, MD and Dawood Sayed, MD discuss minimally invasive procedures for the spine, proper methods of patient selection for interventional pain techniques, and safety and efficacy of patients going forward. The Vertos Medical session, “Redefining the mild® Procedure: Emerging Techniques & Advancing the Treatment Algorithm” is led by Alex Escobar, MD; Denis G. Patterson, DO and Jackie Weisbein, DO.
“One of the many features that we see with innovation comes around optimizing techniques and not recreating something new and what we’ve found through many hours spent in the cadaver lab as well as employing this Streamlined Technique in many of our practices is that we can commonly access both sides of the lamina using the single entry point that we will see in a video shortly.” Dr. Escobar says.
ASPN CME Webinar Series: New Perspectives on Treating Spinal Stenosis with PILD – Evolving the Treatment Algorithm
In this American Society of Pain & Neuroscience (ASPN) webinar, moderators Timothy Deer, MD; Dawood Sayed, MD and faculty members Steven Falowski, MD; Anjum Bux, MD; Peter Pryzbylkowski, MD; Navdeep Jassal, MD; Alex Escobar, MD and Zohra Hussaini, MSN, FNP-BC, MBA, discuss how to evaluate patients to determine appropriate candidates for PILD, use safety and efficacy data to understand where PILD fits in the LSS treatment algorithm, and efficiently educate and manage PILD patients to ensure appropriate treatment expectations are established.
“We know that the effect of epidural steroid injections (ESIs) on symptoms of neurogenic claudication (NC) are limited and they’re short term and, as Anjum mentioned earlier, patients receiving steroids do have increased susceptibility to infection and immunosuppression. So, the great thing about this procedure, you don’t have to use steroids. If you’re worried about taking referrals from your surgical colleagues, I’d encourage you to go to your surgical colleagues and say, ‘Give me the patients you don’t want to operate on and see what I can do for them.’ You’ll be impressed and the patients will go back to those surgeons and then all of a sudden, you’ll see surgeons start to refer more and more to you for patients they don’t want to operate on. You can truly help when you do the decompression procedure. So, spinal comorbidities are not contraindicated, so if patients have disc bulges, disc osteophytes, facet arthropathy, facet hypertrophy, that doesn’t preclude those patients from getting a percutaneous decompression, those patients tend to do very well after we decompress them,” Dr. Pryzbylkowski says.
Rationale and Best Practices for Lumbar Spinal Stenosis (LSS) Identifying and Treating Patients with the mild® Procedure
In this five-part webcast series from Ciné-Med and MediaSphere Medical, Timothy Deer, MD, DABPM, FIPP; Stanley Golovac, MD; Navdeep Jassal, MD and Ashley Comer, APRN, NP-C discuss lumbar spinal stenosis and treatment options, typical lumbar spinal stenosis patients and differentiating symptom types, confirming symptoms with an MRI, integrating LSS identification and efficient patient management into a practice’s routine, and FAQ with those that are mild® providers.
“This activity evaluates the promising strategy of the reimbursable mild® Procedure for treating LSS patients minimally invasively, which restores mobility and reduces pain, while offering a low risk of major complications,” the activity description reads.
Collaboration is one of Vertos Medical’s core values as the company partners with the nation’s leading institutions and healthcare providers to ensure LSS patients have access to mild® as a treatment option. Performed through an incision smaller than the size of a baby aspirin (5.1mm), mild® is a minimally invasive lumbar decompression procedure that removes a major root cause of neurogenic claudication by debulking the hypertrophic ligamentum flavum, which reduces the compression of the nerves. Learn more about how mild®can be a valuable part of your practice.
Benyamin RM, Staats PS, MiDAS ENCORE Investigators. mild® is an effective treatment for lumbar spinal stenosis with neurogenic claudication: MiDAS ENCORE Randomized Controlled Trial. Pain Physician. 2016;19(4):229-242.
Mekhail N, Costandi S, Abraham B, Samuel SW. Functional and patient-reported outcomes in symptomatic lumbar spinal stenosis following percutaneous decompression. Pain Pract. 2012;12(6):417-425. doi:10.1111/j.1533-2500.2012.00565.x.
2012 data from Health Market Sciences report for Vertos Medical 2013.
Data on file with Vertos Medical.
Staats PS, Chafin TB, Golvac S, et al. Long-term safety and efficacy of minimally invasive lumbar decompression procedure for the treatment of lumbar spinal stenosis with neurogenic claudication: 2-year results of MiDAS ENCORE. Reg Anesth Pain Med. 2018;43:789-794. doi:10.1097/AAP.0000000000000868.
Based on mild® Procedure data collected in all clinical studies. Major complications are defined as dural tear and blood loss requiring transfusion.
MiDAS ENCORE responder data. On file with Vertos Medical.
Jain S, Deer TR, Sayed D, et al. Minimally invasive lumbar decompression: a review of indications, techniques, efficacy and safety. Pain Manag. 2020;10(5). https://doi.org/10.2217/pmt-2020-0037. Accessed June 1, 2020.
Deer TR, Grider JS, Pope JE, et al. The MIST Guidelines: the Lumbar Spinal Stenosis Consensus Group guidelines for minimally invasive spine treatment. Pain Pract. 2019;19(3)250-274. doi:10.1111/papr.12744.
Hansson T, Suzuki N, Hebelka H, Gaulitz A. The narrowing of the lumbar spinal canal during loaded MRI: the effects of the disc and ligamentum flavum. Eur Spine J. 2009;18(5):679-686. doi:10.1007/s00586-009-0919-7.
Treatment options shown are commonly offered once conservative therapies (e.g., physical therapy, pain medications, chiropractic) are not providing adequate relief. This is not intended to be a complete list of all treatments available. Doctors typically recommend treatments based on their safety profile, typically prioritizing low risk/less aggressive procedures before higher risk/more aggressive procedures, but will determine which treatments are appropriate for their patients.
The mild® Procedure is a minimally invasive treatment for lumbar spinal stenosis. As with most surgical procedures, serious adverse events, some of which can be fatal, can occur, including heart attack, cardiac arrest (heart stops beating), stroke, and embolism (blood or fat that migrates to the lungs or heart). Other risks include infection and bleeding, spinal cord and nerve injury that can, in rare instances, cause paralysis. This procedure is not for everyone. Physicians should discuss potential risks with patients. For complete information regarding indications for use, warnings, precautions, and methods of use, please reference the devices’Instructions for Use.
Patient stories on this website reflect the results experienced by individuals who have undergone the mild® Procedure. Patients are not compensated for their testimonial. The mild® Procedure is intended to treat lumbar spinal stenosis (LSS) caused by ligamentum flavum hypertrophy. Although patients may experience relief from the procedure, individual results may vary. Individuals may have symptoms persist or evolve or other conditions that require ongoing medication or additional treatments. Please consult with your doctor to determine if this procedure is right for you.
Reimbursement, especially coding, is dynamic and changes every year. Laws and regulations involving reimbursement are also complex and change frequently. Providers are responsible for determining medical necessity and reporting the codes that accurately describe the work that is done and the products and procedures that are furnished to patients. For this reason, Vertos Medical strongly recommends that you consult with your payers, your specialty society, or the AMA CPT regarding coding, coverage and payment.
Vertos Medical cannot guarantee coding, coverage, or payment for products or procedures. View our Billing Guide.
Vertos is an equal employment opportunity workplace committed to pursuing and hiring a diverse workforce. We strive to grow our team with highly skilled people who share our culture and values. All qualified applicants will receive consideration for employment without regard to sex, age, color, race, religion, marital status, national origin, ancestry, sexual orientation, gender identity, physical & mental disability, medical condition, genetic information, veteran status, or any other basis protected by federal, state or local law.
Hall S, Bartleson JD, Onofrio BM, Baker HL Jr, Okazaki H, O’Duffy JD. Lumbar spinal stenosis. Clinical features, diagnostic procedures, and results of surgical treatment in 68 patients. Ann Intern Med. 1985;103(2):271-275. doi:10.7326/0003-4819-103-2-271.
Kalichman L, Cole R, Kim DH, et al. Spinal stenosis prevalence & association with symptoms: The Framingham Study. Spine J. 2009;9(7):545-550. doi:10.1016/j.spinee.2009.03.005.
Fukusaki M, Kobayashi I, Hara T, Sumikawa K. Symptoms of spinal stenosis do not improve after epidural steroid injection. Clin J Pain. 1998;14(2):148-151. doi:10.1097/00002508-199806000-00010.
Mekhail N, Costandi S, Nageeb G, Ekladios C, Saied O. The durability of minimally invasive lumbar decompression procedure in patients with symptomatic lumbar spinal stenosis: Long-term follow-up [published online ahead of print, 2021 May 4]. Pain Pract. 2021;10.1111/papr.13020. doi:10.1111/papr.13020
Friedly JL, Comstock BA, Turner JA, et al. Long-Term Effects of Repeated Injections of Local Anesthetic With or Without Corticosteroid for Lumbar Spinal Stenosis: A Randomized Trial. Arch Phys Med Rehabil. 2017;98(8):1499-1507.e2. doi:10.1016/j.apmr.2017.02.029
Pope J, Deer TR, Falowski SM. A retrospective, single-center, quantitative analysis of adverse events in patients undergoing spinal stenosis with neurogenic claudication using a novel percutaneous direct lumbar decompression strategy. J Pain Res. 2021;14:1909-1913. doi: 10.2147/JPR.S304997
Pryzbylkowski P, Bux A, Chandwani K, et al. Minimally invasive direct decompression for lumbar spinal stenosis: impact of multiple prior epidural steroid injections [published online ahead of print, 2021 Aug 4]. Pain Manag. 2021;10.2217/pmt-2021-0056. doi:10.2217/pmt-2021-0056
Abstract presented at: American Society of Pain and Neuroscience Annual Conference; July 22-25, 2021; Miami Beach, FL.
Mobility Matters: Low Back Pain in America, Harris Poll Survey, 2022. View data and full summary here.
Deer TR, Grider JS, Pope JE, et al. Best Practices for Minimally Invasive Lumbar Spinal Stenosis Treatment 2.0 (MIST): Consensus Guidance from the American Society of Pain and Neuroscience (ASPN). J Pain Res. 2022;15:1325-1354. Published 2022 May 5. doi:10.2147/JPR.S355285.
Physicians: Dannemiller designates this enduring material for a maximum of 1.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physician Assistants: AAPA accepts certificates of participation for educational activities certified for Category 1 credit from AOACCME, prescribed credit from AAFP, and AMA PRA Category 1 Credit™ from organizations accredited by the ACCME. Physician assistants may receive a maximum of 1.50 AMA PRA Category 1 Credit(s)™ for completing this program.
Physicians: Dannemiller designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physician Assistants: AAPA accepts certificates of participation for educational activities certified for Category 1 credit from AOACCME, prescribed credit from AAFP, and AMA PRA Category 1 Credit™ from organizations accredited by the ACCME. Physician assistants may receive a maximum of 1.25 AMA PRA Category 1 Credit(s)™ for completing this program.
Physicians: Dannemiller designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physician Assistants: AAPA accepts certificates of participation for educational activities certified for Category 1 credit from AOACCME, prescribed credit from AAFP, and AMA PRA Category 1 Credit™ from organizations accredited by the ACCME. Physician assistants may receive a maximum of 1.25 AMA PRA Category 1 Credit(s)™ for completing this program.
Physicians: Evolve Medical Education designates this enduring material for a maximum of 1.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.